Reaction
Sputum Purulent reporting signals
As of the last recalculation, Sputum Purulent appears in 654 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 209.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 79 | 209.8 | 211.0 |
| Moxifloxacin Hydrochloride | 56 | 96.0 | 96.3 |
| Mepolizumab | 105 | 79.9 | 80.1 |
| Moxifloxacin | 31 | 73.5 | 73.6 |
| Fluticasone Furoate And Vilanterol Trifenatate | 73 | 72.6 | 72.7 |
| Human Immunoglobulin G | 36 | 58.7 | 58.8 |
| Nicotine Polacrilex Mini | 24 | 52.8 | 52.9 |
| Nicotine Polarilex | 24 | 52.8 | 52.9 |
| Rabeprazole | 34 | 51.5 | 51.5 |
| Acetylcysteine | 12 | 41.3 | 41.3 |
| Antacid | 54 | 39.3 | 39.4 |
| Rabeprazole Sodium | 29 | 35.4 | 35.4 |
| Tiotropium Bromide Inhalation Spray | 12 | 34.7 | 34.7 |
| Amoxicillin And Clavulanate Potassium | 26 | 31.7 | 31.7 |
| Levofloxacin | 48 | 27.3 | 27.3 |
| Levofloxacin In 5% Dextrose | 48 | 27.3 | 27.3 |
| Azelastine | 15 | 27.2 | 27.2 |
| Tiotropium Bromide | 95 | 25.7 | 25.7 |
| Fluticasone Propionate And Salmeterol Xinafoate | 42 | 23.7 | 23.7 |
| Ceftriaxone | 23 | 23.1 | 23.1 |
| Amikacin | 12 | 22.8 | 22.8 |
| Sirolimus | 9 | 21.5 | 21.6 |
| Nicotine Polacrilex | 24 | 20.7 | 20.7 |
| Ceftriaxone Sodium | 24 | 20.6 | 20.6 |
| Nicotine | 24 | 19.6 | 19.6 |
| Linezolid | 14 | 15.3 | 15.3 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 6 | 11.5 | 11.5 |